PI
STRO icon

Putnam Investments’s Sutro Biopharma STRO Stock Holding History

Putnam Investments’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,839
Closed -$237K – 1220
2023
Q3 		$237K Sell
6,839
-60
-0.9% -$2.61K ﹤0.01% 1111
2023
Q2 		$321K Sell
6,899
-215
-3% -$10.7K ﹤0.01% 1071
2023
Q1 		$329K Buy
+7,114
New +$451K ﹤0.01% 1069

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Putnam Investments's STRO Position: Q4 2023 in Review

Putnam Investments sold out of Sutro Biopharma (STRO) in Q4 2023, closing a stake of 6,839 shares — an estimated $237K sold.

Putnam Investments first reported a position in STRO in Q1 2023 and held it in 3 quarters. The position peaked at $329K in Q1 2023. 114 funds tracked by Wall St. Rank hold STRO as of Q4 2023.

  • Putnam Investments reported no remaining Sutro Biopharma position as of Q4 2023 after selling out during the quarter.
  • Putnam Investments sold 6,839 Sutro Biopharma shares in Q4 2023, an estimated $237K.
  • Putnam Investments first reported a position in Sutro Biopharma in Q1 2023 and held it in 3 quarters.
  • Putnam Investments's Sutro Biopharma position peaked at $329K in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.